Why do patients with atrial fibrillation not receive warfarin?

Atrial fibrillation (AF) is a growing public health problem associated with significant morbidity and mortality. Numerous randomized controlled trials of warfarin have conclusively demonstrated that long-term anticoagulation therapy can reduce the risk for stroke by approximately 68% per year in patients with nonvalvular AF, and even more in patients with valvular AF. However, available data show that of those patients with AF and no contraindication to warfarin therapy, only 15% to 44% are prescribed warfarin. Our literature review has identified patient-, physician-, and health care system-related barriers to warfarin prescription. However, the relative importance of these specific barriers remains unknown. Further work is needed to understand the discrepancy between the randomized controlled trial evidence and clinical practice patterns.

[1]  J. Wasson,et al.  Physician variation in anticoagulating patients with atrial fibrillation. Dartmouth Primary Care COOP Project. , 1990, Archives of internal medicine.

[2]  R. Asinger,et al.  Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force. , 1989, Archives of neurology.

[3]  S. Kemp,et al.  Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals , 1997, Neurology.

[4]  L K Gottlieb,et al.  Anticoagulation in Atrial Fibrillation: Does Efficacy in Clinical Trials Translate Into Effectiveness in Practice? , 1994 .

[5]  Bernard Rosner,et al.  The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. , 1990, The New England journal of medicine.

[6]  G. Lip,et al.  Physician variation in the management of patients with atrial fibrillation. , 1996, Heart.

[7]  G. MacGregor,et al.  Survey of use of anticoagulation in patients with atrial fibrillation. , 1993, BMJ.

[8]  B. O. Williams,et al.  Antithrombotic Therapy Prescribed for Patients with Non-Rheumatic Atrial Fibrillation , 1994, Scottish medical journal.

[9]  S. Connolly,et al.  Stroke prevention in nonvalvular atrial fibrillation. , 1991, Annals of internal medicine.

[10]  Palle Petersen,et al.  PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.

[11]  J. Avorn,et al.  Atrial fibrillation and stroke prevention with warfarin in the long-term care setting. , 1997, Archives of internal medicine.

[12]  J. Bell,et al.  Physician Variation in Anticoagulating Patients With Atrial Fibrillation , 1990 .

[13]  A. Mcguire,et al.  Cost-effectiveness of anticoagulation in nonrheumatic atrial fibrillation in the primary prevention of ischemic stroke. , 1998, Stroke.

[14]  F. Silverstone,et al.  Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. , 1991, Archives of internal medicine.

[15]  P. Duncan,et al.  Primary Stroke Prevention in Nonvalvular Atrial Fibrillation: Implementing the Clinical Trial Findings , 1997, The Annals of pharmacotherapy.

[16]  M Gent,et al.  Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. , 1991, Journal of the American College of Cardiology.

[17]  F. Dunn,et al.  Treatment of atrial fibrillation in a district general hospital. , 1994, British heart journal.

[18]  G. Page,et al.  Performance on PMPs and performance in practice: are they related? , 1980, Journal of medical education.

[19]  A Laupacis,et al.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. , 1995, Archives of internal medicine.

[20]  G. Lip.  Many patients are ineligible , 1996, BMJ.

[21]  J. Hanlon,et al.  Do Older Women Use Estrogen Replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE) , 1996, Journal of the American Geriatrics Society.

[22]  H. Mcelroy,et al.  Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment , 1998, BMJ.

[23]  Rose Anne Kenny,et al.  Prevalence of atrial fibrillation and eligibility for anticoagulants in the community , 1998, The Lancet.

[24]  P. Wolf,et al.  Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. , 1987, Archives of internal medicine.

[25]  T. Cheng.  Thromboembolism prophylaxis in chronic atrial fibrillation: practice patterns in community and tertiary-care hospitals. , 1997, Stroke.

[26]  M. Brodsky,et al.  Regional attitudes of generalists, specialists, and subspecialists about management of atrial fibrillation. , 1996, Archives of internal medicine.

[27]  Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators. , 1998, The Canadian journal of cardiology.

[28]  D. Singer,et al.  National patterns of warfarin use in atrial fibrillation. , 1996, Archives of internal medicine.

[29]  C. Harris,et al.  Case History Questionnaires in the Study of Doctors' Use of Resources: Are They Measuring What We Want? , 1985, Medical care.

[30]  J. Whittle,et al.  Is warfarin underused in the treatment of elderly persons with atrial fibrillation? , 1997, Archives of internal medicine.

[31]  M. Roland,et al.  Analysis of referral behaviour: responses to simulated case histories may not reflect real clinical behaviour. , 1990, The British journal of general practice : the journal of the Royal College of General Practitioners.

[32]  A D Oxman,et al.  Changing physician performance. A systematic review of the effect of continuing medical education strategies. , 1995, JAMA.

[33]  F. McAlister,et al.  The Utilization of Antithrombotic Prophylaxis for Atrial Fibrillation in a Geriatric Rehabilitation Hospital , 1996, Journal of the American Geriatrics Society.

[34]  Warfarin anticoagulation in primary care: a regional survey of present practice and clinicians' views. , 1997, The British journal of general practice : the journal of the Royal College of General Practitioners.

[35]  R. Thomson,et al.  How To Do It: Service provision and use of anticoagulants in atrial fibrillation , 1995, BMJ.

[36]  L. Poller,et al.  Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. , 1993, The New England journal of medicine.

[37]  J. Voke,et al.  Anticoagulation in patients with atrial fibrillation. GPs not prepared for monitoring anticoagulation. , 1993, BMJ.

[38]  M S Gerrity,et al.  Written case simulations: do they predict physicians' behavior? , 1990, Journal of clinical epidemiology.

[39]  F Sturmans,et al.  Does competence of general practitioners predict their performance? Comparison between examination setting and actual practice. , 1991, BMJ.

[40]  N. Vu.  Medical problem-solving assessment: a review of methods and instruments. , 1979, Evaluation & the health professions.

[41]  Lippincott Williams Wilkins,et al.  Stroke Prevention in Atrial Fibrillation Study: Final Results , 1991, Circulation.

[42]  Eaft Study Group.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993, The Lancet.

[43]  H. Krumholz,et al.  Warfarin use among patients with atrial fibrillation. , 1997, Stroke.

[44]  G. Lip,et al.  Original papers , 2013 .

[45]  G. Samsa,et al.  Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. , 1995, Archives of internal medicine.

[46]  H. Sandvik.  Criterion validity of responses to patient vignettes: an analysis based on management of female urinary incontinence. , 1995, Family medicine.

[47]  A. Laupacis,et al.  Warfarin for atrial fibrillation. The patient's perspective. , 1996, Archives of internal medicine.

[48]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[49]  A. Belanger,et al.  The Framingham study. , 1976, British medical journal.

[50]  J. Avorn,et al.  Physician Attitudes Concerning Warfarin for Stroke Prevention in Atrial Fibrillation: Results of a Survey of Long‐Term Care Practitioners , 1997, Journal of the American Geriatrics Society.

[51]  J. O'connell,et al.  Atrial fibrillation and stroke prevention in the community. , 1996, Age and ageing.